These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15425893)

  • 21. METABOLISM OF MICROORGANISMS AS RELATED TO THEIR PATHOGENICITY.
    PANOS C; AJL SJ
    Annu Rev Microbiol; 1963; 17():297-328. PubMed ID: 14147454
    [No Abstract]   [Full Text] [Related]  

  • 22. Separation of pertussal toxin.
    ROBBINS KC; PILLEMER L
    Proc Soc Exp Biol Med; 1950 May; 74(1):75-8. PubMed ID: 15430395
    [No Abstract]   [Full Text] [Related]  

  • 23. [Carbohydrate metabolism in Bac. perfringens (Cl. welchii) type A and synthesis of individual components of its toxin].
    IAROSHENKO VA
    Mikrobiol Zh; 1959; 21(3)():3-8. PubMed ID: 14405835
    [No Abstract]   [Full Text] [Related]  

  • 24. The relation of toxicity and enzyme activity in the lecithinases of clostridium bifermentans and clostridium welchii.
    MILES EM; MILES AA
    J Gen Microbiol; 1950 Jan; 4(1):22-35. PubMed ID: 15415553
    [No Abstract]   [Full Text] [Related]  

  • 25. FIFTH INTERNATIONAL STANDARD FOR GAS-GANGRENE ANTITOXIN (PERFRINGENS) (CLOSTRIDIUM WELCHII TYPE A ANTITOXIN).
    EVANS DG; PERKINS FT
    Bull World Health Organ; 1963; 29(6):729-35. PubMed ID: 14107745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ACTION OF PROTEINASE OF CLOSTRIDIUM OEDEMATIENS AND CLOSTRIDIUM PERFRINGENS ON HOMOLOGOUS AND HETEROLOGOUS TOXINS].
    SHEMANOVA GF; VLASOVA EV; SHAMRAEVA SA
    Biull Eksp Biol Med; 1964 Apr; 13():80-3. PubMed ID: 14248428
    [No Abstract]   [Full Text] [Related]  

  • 27. Type II toxin: antitoxin systems. More than small selfish entities?
    Rocker A; Meinhart A
    Curr Genet; 2016 May; 62(2):287-90. PubMed ID: 26597447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Structure and function of Cl. perfringens toxin].
    Ispolatovskaia MV
    Vestn Akad Med Nauk SSSR; 1973; 28(11):83-9. PubMed ID: 4132138
    [No Abstract]   [Full Text] [Related]  

  • 29. Structure-function analysis of VapB4 antitoxin identifies critical features of a minimal VapC4 toxin-binding module.
    Jin G; Pavelka MS; Butler JS
    J Bacteriol; 2015 Apr; 197(7):1197-207. PubMed ID: 25622615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A note on the deterioration of diphtheria and tetanus antitoxins.
    GLENNY AT
    Q J Pharm Pharmacol; 1945; 18():383. PubMed ID: 21015310
    [No Abstract]   [Full Text] [Related]  

  • 31. Methods for the production of the alpha and theta toxins of Clostridium welchii.
    ADAMS MH; HENDEE ED
    J Immunol; 1945 Oct; 51():249-56. PubMed ID: 21003540
    [No Abstract]   [Full Text] [Related]  

  • 32. [Destructive or antidotic properties of B. subtilis culture filtrates with regard to microbial toxins].
    RAMON G; RICHOU R
    Bull Acad Med; 1946; 130(6-8):98-102. PubMed ID: 21023911
    [No Abstract]   [Full Text] [Related]  

  • 33. [The role of alpha, beta and epsilon factors in W. perfringens agni (A, C and D) toxin on the development of bacteremia in toxic enteritis].
    KATITCH R; PUHATCH I; VUKITCHEVITCH Z
    Rev Immunol Ther Antimicrob; 1959; 23():294-8. PubMed ID: 14404725
    [No Abstract]   [Full Text] [Related]  

  • 34. sRNAs in bacterial type I and type III toxin-antitoxin systems.
    Brantl S; Jahn N
    FEMS Microbiol Rev; 2015 May; 39(3):413-27. PubMed ID: 25808661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Determinants for Antitoxin Identity and Insulation of Cross Talk between Homologous Toxin-Antitoxin Systems.
    Walling LR; Butler JS
    J Bacteriol; 2016 Dec; 198(24):3287-3295. PubMed ID: 27672196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on electrophoretic properties of phospholipase from B. perfringens toxin during the process of detoxication].
    ISPOLATOVSKAIA MV; LARINA Ia
    Biokhimiia; 1959; 24():738-44. PubMed ID: 14405954
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the toxicology and pharmacology of gas gangrene toxin (Clostridium welchii type A) and its components].
    HABERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 238():502-24. PubMed ID: 13830673
    [No Abstract]   [Full Text] [Related]  

  • 38. [Detoxication of partially purified and concentrated Cl. perfringens toxin].
    BLASKO B
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Apr; 33():110-5. PubMed ID: 13869875
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of electrocardiography in experimental intoxication with Clostridium perfringens A toxin].
    ORESCANIN B; ANTIC R; ISVANESKI M
    Acta Med Iugosl; 1960; 14():433-45. PubMed ID: 13731136
    [No Abstract]   [Full Text] [Related]  

  • 40. [The toxin production capacity of strains of the perfringens group in the light of the comparative quantitative analyses of the toxic antigens in culture fluids, cell extracts and spore extracts].
    MEISEL H; ALBRYCHT H; RYMKIEWICZ D
    Pathol Microbiol (Basel); 1962; 25():67-78. PubMed ID: 14472252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.